Viewing Study NCT00481559

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT00481559
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2014-01-17
First Post: 2007-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
Sponsor: BTG International Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Voraxaze View
None glucarpidase View
None carboxypeptidase View
None cancer View
None lymphoma View
None leukemia View
None osteosarcoma View
None methotrexate View
None delayed elimination View
None renal insufficiency View
None toxicity View